Secukinumab, a novel anti–IL-17A antibody, shows low immunogenicity potential in human in vitro assays comparable to other marketed biotherapeutics with low clinical immunogenicity
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Secukinumab, a novel anti–IL-17A antibody, shows low immunogenicity potential in human in vitro assays comparable to other marketed biotherapeutics with low clinical immunogenicity
Authors
Keywords
-
Journal
mAbs
Volume 8, Issue 3, Pages 536-550
Publisher
Informa UK Limited
Online
2016-01-28
DOI
10.1080/19420862.2015.1136761
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium
- (2015) B. Rup et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Determinants of immunodominance for CD4 T cells
- (2015) AeRyon Kim et al. CURRENT OPINION IN IMMUNOLOGY
- Immunogenicity of Biotherapy Used in Psoriasis: The Science Behind the Scenes
- (2015) Denis Jullien et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2015) Iain B McInnes et al. LANCET
- Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
- (2015) Philip J. Mease et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessment and Reporting of the Clinical Immunogenicity of Therapeutic Proteins and Peptides—Harmonized Terminology and Tactical Recommendations
- (2014) G. Shankar et al. AAPS Journal
- Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial
- (2014) Christopher Ritchlin et al. ANNALS OF THE RHEUMATIC DISEASES
- Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE)
- (2014) A. Blauvelt et al. BRITISH JOURNAL OF DERMATOLOGY
- Functional Analysis of the Anti-adalimumab Response Using Patient-derived Monoclonal Antibodies
- (2014) Pauline A. van Schouwenburg et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Prevalence of TNF- Blocker Immunogenicity in Psoriatic Arthritis
- (2014) M. Zisapel et al. JOURNAL OF RHEUMATOLOGY
- Efficacy, safety and usability of secukinumab administration by autoinjector/pen in psoriasis: a randomized, controlled trial (JUNCTURE)
- (2014) C. Paul et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
- (2014) Richard G. Langley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aggregation of Human Recombinant Monoclonal Antibodies Influences the Capacity of Dendritic Cells to Stimulate Adaptive T-Cell Responses In Vitro
- (2014) Verena Rombach-Riegraf et al. PLoS One
- Adalimumab serum levels and antidrug antibodies towards adalimumab in peripheral spondyloarthritis: no association with clinical response to treatment or with disease relapse upon treatment discontinuation
- (2014) Jacqueline E Paramarta et al. ARTHRITIS RESEARCH & THERAPY
- A178: Development of Tools to Facilitate Shared Decision Making about Medications for Juvenile Idiopathic Arthritis-A Project of the Pediatric Rheumatology Care and Outcomes Improvement Network
- (2014) Esi Morgan DeWitt et al. Arthritis & Rheumatology
- Influence of neutralizing antibodies to adalimumab and infliximab on the treatment of psoriasis
- (2013) T. Bito et al. BRITISH JOURNAL OF DERMATOLOGY
- Antidrug antibodies in psoriasis: a systematic review
- (2013) L. Hsu et al. BRITISH JOURNAL OF DERMATOLOGY
- T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation
- (2013) Vibha Jawa et al. CLINICAL IMMUNOLOGY
- Immunogenicity of anti-TNFα therapy in psoriasis: a clinical issue?
- (2013) Clara De Simone et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Anti-drug antibodies in psoriasis: a critical evaluation of clinical significance and impact on treatment response
- (2013) Leeyen Hsu et al. Expert Review of Clinical Immunology
- A strategy to determine HLA class II restriction broadly covering the DR, DP, and DQ allelic variants most commonly expressed in the general population
- (2013) Denise M. McKinney et al. IMMUNOGENETICS
- Immunogenicity of therapeutic proteins: Influence of aggregation
- (2013) Kirsty D. Ratanji et al. Journal of Immunotoxicology
- Immunogenicity/Hypersensitivity of Biologics
- (2013) Michael W. Leach et al. TOXICOLOGIC PATHOLOGY
- Rituximab for the treatment of rheumatoid arthritis: an update
- (2013) Chi Chiu Mok Drug Design Development and Therapy
- Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study
- (2012) Mark C Genovese et al. ANNALS OF THE RHEUMATIC DISEASES
- Comparison of long-term clinical outcome with etanercept treatment and adalimumab treatment of rheumatoid arthritis with respect to immunogenicity
- (2012) Charlotte L. Krieckaert et al. ARTHRITIS AND RHEUMATISM
- Highly Aggregated Antibody Therapeutics Can Enhance thein VitroInnate and Late-stage T-cell Immune Responses
- (2012) Marisa K. Joubert et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- T Cell Responses to Known Allergen Proteins Are Differently Polarized and Account for a Variable Fraction of Total Response to Allergen Extracts
- (2012) C. Oseroff et al. JOURNAL OF IMMUNOLOGY
- The Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings
- (2012) David A. Martin et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nitration of the Pollen Allergen Bet v 1.0101 Enhances the Presentation of Bet v 1-Derived Peptides by HLA-DR on Human Dendritic Cells
- (2012) Anette C. Karle et al. PLoS One
- Dissecting the T Cell Response: Proliferation Assays vs. Cytokine Signatures by ELISPOT
- (2012) Donald D. Anthony et al. Cells
- Mast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis
- (2011) A. M. Lin et al. JOURNAL OF IMMUNOLOGY
- 124I-huA33 Antibody PET of Colorectal Cancer
- (2011) J. A. Carrasquillo et al. JOURNAL OF NUCLEAR MEDICINE
- Overcoming immunogenicity associated with the use of biopharmaceuticals
- (2011) Michael G Tovey et al. Expert Review of Clinical Pharmacology
- Relationship between the clinical response to adalimumab treatment and serum levels of adalimumab and anti-adalimumab antibodies in patients with psoriatic arthritis
- (2010) A. W. R. van Kuijk et al. ANNALS OF THE RHEUMATIC DISEASES
- Considerations for optimization and validation of an in vitro PBMC derived T cell assay for immunogenicity prediction of biotherapeutics
- (2010) Danika Wullner et al. CLINICAL IMMUNOLOGY
- Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
- (2010) R. F. van VOLLENHOVEN et al. JOURNAL OF RHEUMATOLOGY
- Immunotoxicity of monoclonal antibodies
- (2010) Jacques Descotes mAbs
- The immunogenicity of humanized and fully human antibodies
- (2010) Fiona A. Harding et al. mAbs
- Development trends for human monoclonal antibody therapeutics
- (2010) Aaron L. Nelson et al. NATURE REVIEWS DRUG DISCOVERY
- Overrepresentation of IL-17A and IL-22 Producing CD8 T Cells in Lesional Skin Suggests Their Involvement in the Pathogenesis of Psoriasis
- (2010) Pieter C. M. Res et al. PLoS One
- The effect of immunomodulators on the immunogenicity of TNF-blocking therapeutic monoclonal antibodies: a review
- (2010) Charlotte Krieckaert et al. ARTHRITIS RESEARCH & THERAPY
- T cell epitope: Friend or Foe? Immunogenicity of biologics in context☆
- (2009) Constanze A. Weber et al. ADVANCED DRUG DELIVERY REVIEWS
- Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation
- (2009) M K de Vries et al. ANNALS OF THE RHEUMATIC DISEASES
- Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin
- (2009) C. Johansen et al. BRITISH JOURNAL OF DERMATOLOGY
- Immunogenicity of Anti-TNF-α Agents in Autoimmune Diseases
- (2009) Nádia Emi Aikawa et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- A New Monoclonal Antibody Recognizing a Linear Determinant on the HLA-DRα Chain N-terminus
- (2009) Yi Tian Ting et al. HYBRIDOMA
- The HLA genomic loci map: expression, interaction, diversity and disease
- (2009) Takashi Shiina et al. JOURNAL OF HUMAN GENETICS
- IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines
- (2009) Consuelo Ortega et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells
- (2008) Michelle A. Lowes et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More